Comparison of Compressed Continuous Suture and Conventional Suture in Pterygium Surgery

November 21, 2025 updated by: Tianjin Eye Hospital

Comparison of Compression Continuous Suture Versus Conventional Suture for Autologous Conjunctival Implant Fixation in Primary Pterygium Surgery: a Randomized Controlled Trial

To compare the advantages and disadvantages of continuous suture with suture and conventional Suture in primary pterygium surgery for autologous conjunctival graft fixation

Study Overview

Detailed Description

Pterygium is an abnormal fibrovascular tissue hyperplasia disease that occurs in the conjunctiva. The pterygium tissue can break through the limbus of the corneosclera and grow into the cornea, causing a foreign body sensation in the eyes, astigmatism, decreased vision, and even restricted eye movement. The purpose of surgical treatment for pterygium is not only to remove the diseased tissue, but more importantly, to reduce the recurrence of pterygium after surgery. Pterygium excision combined with simple autologous conjunctival transplantation is currently the most commonly used method for treating pterygium. The recurrence rate after autologous conjunctival epithelial tissue transplantation can be reduced to 5% to 30%.

As heterogenic substances, sutures can irritate the ocular surface, aggravate postoperative inflammatory reactions and conjunctival edema or hemorrhage, delay the repair of corneal wound epithelium, lead to abnormal ocular surface function, intensify postoperative discomfort, and induce hypertrophic granuloma or cysts, etc. Moreover, these adverse reactions can also induce the recurrence of pterygium (0-26%). In addition, the longer the time interval between suture removal, The greater the difficulty of removal, the more likely some of the knots may be completely buried under the conjunctiva. Therefore, in order to alleviate the adverse reactions caused by sutures and further simplify the operation of pterygium excision surgery, many attempts have been made at home and abroad to improve and innovate the method of graft fixation.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Tianjin Municipality
      • Tianjin, Tianjin Municipality, China
        • Recruiting
        • Tianjin Eye Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Diagnosis of primary pterygium according to diagnostic criteria;
  2. The pterygium head invades the cornea by 2-5mm;
  3. The patient agrees to the surgical treatment and signs the surgical consent form.

Exclusion Criteria:

  1. History of previous eye surgery;
  2. Have active ocular inflammatory lesions;
  3. recurrent and pseudopterygium;
  4. The patient refuses surgery or is unable to have regular follow-ups

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Continuous suture group
Pterygium excision combined with autologous conjunctival transplantation was performed
Pterygium excision combined with autologous conjunctival transplantation was performed, and the continuous suture method with pressure lines was adopted during the operation
Other: Intermittent suture group
Pterygium excision combined with autologous conjunctival transplantation was performed
Pterygium excision combined with autologous conjunctival transplantation was performed, and the traditional suture method was adopted during the operation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of surgery
Time Frame: Intraoperative
The date on which the surgery was performed
Intraoperative
Implant stability
Time Frame: Postoperative follow-up was performed 1 day and 1 week after surgery
Whether the conjunctival graft is loose or detached
Postoperative follow-up was performed 1 day and 1 week after surgery
Postoperative discomfort
Time Frame: Postoperative follow-up was performed 1 day and 1 week after surgery
The degree of discomfort after surgery was evaluated using the VAS Pain score Scale
Postoperative follow-up was performed 1 day and 1 week after surgery
Stitch removal time
Time Frame: Postoperative follow-up was performed 1 week after surgery
The date when the stitches were removed
Postoperative follow-up was performed 1 week after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Yi Zhang, Tianjin Eye Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 2, 2024

Primary Completion (Estimated)

April 2, 2026

Study Completion (Estimated)

July 2, 2026

Study Registration Dates

First Submitted

August 8, 2025

First Submitted That Met QC Criteria

November 21, 2025

First Posted (Actual)

November 24, 2025

Study Record Updates

Last Update Posted (Actual)

November 24, 2025

Last Update Submitted That Met QC Criteria

November 21, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • zhangyi2025

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Primary Pterygium

Clinical Trials on Compression continuous suture with suture crimping

Subscribe